Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Inclusion of under-served groups in trials: an audit at a UK primary care clinical trials unit.

Burrow R. et al, (2025), Trials, 26

SWAR 42: Impact of excluding conference abstracts when undertaking a systematic review

BURROW R. and Clarke M., (2024)

Inclusion in trials during pregnancy

BURROW R., (2024)

Do pregnant people have opportunities to participate in clinical trials? An exploratory survey of NIHR HTA-funded trialists

BURROW R. et al, (2024)

Inclusion of under-served groups in trials: an audit at a UK primary care clinical trials unit

BURROW R. et al, (2024)

Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis

Wynberg E. et al, (2023), Malaria Journal, 22

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?

Campbell C. et al, (2023), Wellcome Open Research, 7

Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data

Mansoor R. et al, (2022), BMC Medicine, 20

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?

Campbell C. et al, (2022)

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?

Campbell C. et al, (2022)

The WorldWide Antimalarial Resistance Network Clinical Trials Publication Library: A Live, Open-Access Database of Plasmodium Treatment Efficacy Trials.

Takata J. et al, (2020), Am J Trop Med Hyg, 103, 359 - 368

What clinical features or scoring system, if any, might best predict a benefit from hospital admissions for patients with COVID-19?

BURROW R. et al, (2020)

NEWS (or NEWS2) score when assessing possible COVID-19 patients in primary care?

BURROW R. et al, (2020)

Diagnostic accuracy of molecular methods for detecting markers of antimalarial drug resistance in clinical samples of Plasmodium falciparum: Protocol for an update to a systematic review and meta-analysis

Burrow R. et al, (2018), Systematic Reviews, 7

Clinical implications of Plasmodium resistance to atovaquone/proguanil: A systematic review and meta-analysis

Staines HM. et al, (2018), Journal of Antimicrobial Chemotherapy, 73, 581 - 595

SWAR 06: Measuring the time taken for activities in systematic reviews to identify the most rewarding targets to test strategies that might save time

BURROW R. and Clarke M., (2017)

SWAR08: Finding eligible studies efficiently

BURROW R. and Clarke M., (2017)

Phase 1 Trials of rVSV Ebola vaccine in Africa and Europe

Agnandji ST. et al, (2016), New England Journal of Medicine, 374, 1647 - 1660

The Mu subunit of Plasmodium falciparum clathrin-associated adaptor protein 2 modulates in vitro parasite response to artemisinin and quinine

Henriques G. et al, (2015), Antimicrobial Agents and Chemotherapy, 59, 2540 - 2547

Detection of single-nucleotide polymorphisms in Plasmodium falciparum by PCR primer extension and lateral flow immunoassay

Moers APHA. et al, (2015), Antimicrobial Agents and Chemotherapy, 59, 365 - 371

Load More